KOSEN 한인과학기술자네트워크

닫기

더 많은 혜택을 위해
로그인 하세요.

지식나눔

지식나눔

02월 베스트 답변상

간찬주
lskylov1004
자세히보기

3월 베스트 답변상 후보

담당자

(042) 869-1764

연구하면서 관련 논문에서 질문드립니다.

2023-03-09 org.kosen.entty.User@2300b2f5 익명
  • 1

첨부파일

"DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants"

위의 논문을 보던 중에 APOL1G2/G2 kidney organoids에 DGAT2i를 처리하였을때 lipid droplet이 증가하는 이유를 정확히 이해하지 못하겠습니다. 혹시 이해되시는 분은 설명부탁드립니다. 감사합니다. 

참고파일 참고 부탁드립니다.

  • apolipoprotein L1
답변하시면 KOSEN X 한국과학창의재단 교육기부 봉사활동으로
봉사시간 30분을 인정해 드립니다.
답변하기
답변 1
  • 답변

    한민준님의 답변

    2023-03-13
    • 2
    We previously demonstrated the protective effect of promoting LD formation in the context of APOL1 risk variant
    overexpression.4 DGAT1 and DGAT2 are key enzymes
    important for the final step in LD formation. DGAT1 inhibition is known to inhibit LD formation thus leading to a
    reduction in the number of LDs in cells, but some studies
    have shown that DGAT2 inhibition can lead to a paradoxical increase of LDs.40？42 Therefore, we hypothesized that
    DGAT2 inhibition could increase both LD size and number, leading to both recruitment of APOL1G2/G2 and
    improved cell survival
    답변수정
    We previously demonstrated the protective effect of promoting LD formation in the context of APOL1 risk variant
    overexpression.4 DGAT1 and DGAT2 are key enzymes
    important for the final step in LD formation. DGAT1 inhibition is known to inhibit LD formation thus leading to a
    reduction in the number of LDs in cells, but some studies
    have shown that DGAT2 inhibition can lead to a paradoxical increase of LDs.40？42 Therefore, we hypothesized that
    DGAT2 inhibition could increase both LD size and number, leading to both recruitment of APOL1G2/G2 and
    improved cell survival
    등록된 댓글이 없습니다.

    게시

    비공개 댓글
목록
목록